Peptide Hormones Market 2027 By Type, Route of Administration, and Geography | The Insight Partners

Peptide Hormones Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type (Follicle-stimulating Hormone and Luteinizing Hormone, Adrenocorticotropic Hormone, Growth Hormones, Erythropoietin, Insulin); Route of Administration (Parenteral, Oral, Mucosal, Pulmonary, Others), and Geography

Report Code: TIPRE00009669 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Peptide hormones are proteins whose molecules are peptides or proteins, respectively. These peptides activates steroid hormone synthesis at multiple sites in the body. Like all peptides and proteins, peptide hormones and protein hormones are synthesized in cells from amino acids as per the mRNA transcripts.

MARKET DYNAMICS

Increasing in demand for hormone therapy and advancements in the field of pharmaceuticals are likely to augment the growth of peptide hormones market over the years to come. Furthermore, focus of new entrants and established players in the emerging markets are expected to provide growth opportunities in the market.

MARKET SCOPE

The "Global Peptide Hormones Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Peptide hormones market with detailed market segmentation by, type and route of administration, and geography. The global peptide hormones market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading peptide hormones market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global peptide hormones market is segmented on the basis of type and route of administration. Based on type, it is classified into follicle-stimulating hormone and luteinizing hormone, adrenocorticotropic hormone, growth hormones, erythropoietin, and insulin. Based on route of administration, it is divided into parenteral, oral, mucosal, pulmonary, and others.
?

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global peptide hormones market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Peptide hormones Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting peptide hormones market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the peptide hormones market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the peptide hormones market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from peptide hormones market are anticipated to lucrative growth opportunities in the future with the rising demand for Peptide hormones market in the global market. Below mentioned is the list of few companies engaged in the Peptide hormones Market.

The report also includes the profiles of key peptide hormones market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- BioPartners
- Boehringer Ingelheim GmbH
- Eli Lily and Company
- Innovate Biopharmaceuticals
- Merck KGaA
- Novo Nordisk
- Pfizer, Inc.
- F. Hoffman-La-Roche Ltd.
- Sanofi
- Tarix Pharmaceuticals

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization `options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Peptide Hormone Market - By Type
1.3.2 Peptide Hormone Market - By Route of Administration
1.3.3 Peptide Hormone Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PEPTIDE HORMONE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PEPTIDE HORMONE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. PEPTIDE HORMONE MARKET - GLOBAL MARKET ANALYSIS
6.1. PEPTIDE HORMONE - GLOBAL MARKET OVERVIEW
6.2. PEPTIDE HORMONE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PEPTIDE HORMONE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. FOLLICLE-STIMULATING HORMONE AND LUTEINIZING HORMONE
7.3.1. Overview
7.3.2. Follicle-stimulating Hormone and Luteinizing Hormone Market Forecast and Analysis
7.4. ADRENOCORTICOTROPIC HORMONE
7.4.1. Overview
7.4.2. Adrenocorticotropic Hormone Market Forecast and Analysis
7.5. GROWTH HORMONES
7.5.1. Overview
7.5.2. Growth Hormones Market Forecast and Analysis
7.6. ERYTHROPOIETIN
7.6.1. Overview
7.6.2. Erythropoietin Market Forecast and Analysis
7.7. INSULIN
7.7.1. Overview
7.7.2. Insulin Market Forecast and Analysis
8. PEPTIDE HORMONE MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. PARENTERAL
8.3.1. Overview
8.3.2. Parenteral Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
8.5. MUCOSAL
8.5.1. Overview
8.5.2. Mucosal Market Forecast and Analysis
8.6. PULMONARY
8.6.1. Overview
8.6.2. Pulmonary Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. PEPTIDE HORMONE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Peptide Hormone Market Overview
9.1.2 North America Peptide Hormone Market Forecasts and Analysis
9.1.3 North America Peptide Hormone Market Forecasts and Analysis - By Type
9.1.4 North America Peptide Hormone Market Forecasts and Analysis - By Route of Administration
9.1.5 North America Peptide Hormone Market Forecasts and Analysis - By Countries
9.1.5.1 United States Peptide Hormone Market
9.1.5.1.1 United States Peptide Hormone Market by Type
9.1.5.1.2 United States Peptide Hormone Market by Route of Administration
9.1.5.2 Canada Peptide Hormone Market
9.1.5.2.1 Canada Peptide Hormone Market by Type
9.1.5.2.2 Canada Peptide Hormone Market by Route of Administration
9.1.5.3 Mexico Peptide Hormone Market
9.1.5.3.1 Mexico Peptide Hormone Market by Type
9.1.5.3.2 Mexico Peptide Hormone Market by Route of Administration
9.2. EUROPE
9.2.1 Europe Peptide Hormone Market Overview
9.2.2 Europe Peptide Hormone Market Forecasts and Analysis
9.2.3 Europe Peptide Hormone Market Forecasts and Analysis - By Type
9.2.4 Europe Peptide Hormone Market Forecasts and Analysis - By Route of Administration
9.2.5 Europe Peptide Hormone Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Peptide Hormone Market
9.2.5.1.1 Germany Peptide Hormone Market by Type
9.2.5.1.2 Germany Peptide Hormone Market by Route of Administration
9.2.5.2 France Peptide Hormone Market
9.2.5.2.1 France Peptide Hormone Market by Type
9.2.5.2.2 France Peptide Hormone Market by Route of Administration
9.2.5.3 Italy Peptide Hormone Market
9.2.5.3.1 Italy Peptide Hormone Market by Type
9.2.5.3.2 Italy Peptide Hormone Market by Route of Administration
9.2.5.4 Spain Peptide Hormone Market
9.2.5.4.1 Spain Peptide Hormone Market by Type
9.2.5.4.2 Spain Peptide Hormone Market by Route of Administration
9.2.5.5 United Kingdom Peptide Hormone Market
9.2.5.5.1 United Kingdom Peptide Hormone Market by Type
9.2.5.5.2 United Kingdom Peptide Hormone Market by Route of Administration
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Peptide Hormone Market Overview
9.3.2 Asia-Pacific Peptide Hormone Market Forecasts and Analysis
9.3.3 Asia-Pacific Peptide Hormone Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Peptide Hormone Market Forecasts and Analysis - By Route of Administration
9.3.5 Asia-Pacific Peptide Hormone Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Peptide Hormone Market
9.3.5.1.1 Australia Peptide Hormone Market by Type
9.3.5.1.2 Australia Peptide Hormone Market by Route of Administration
9.3.5.2 China Peptide Hormone Market
9.3.5.2.1 China Peptide Hormone Market by Type
9.3.5.2.2 China Peptide Hormone Market by Route of Administration
9.3.5.3 India Peptide Hormone Market
9.3.5.3.1 India Peptide Hormone Market by Type
9.3.5.3.2 India Peptide Hormone Market by Route of Administration
9.3.5.4 Japan Peptide Hormone Market
9.3.5.4.1 Japan Peptide Hormone Market by Type
9.3.5.4.2 Japan Peptide Hormone Market by Route of Administration
9.3.5.5 South Korea Peptide Hormone Market
9.3.5.5.1 South Korea Peptide Hormone Market by Type
9.3.5.5.2 South Korea Peptide Hormone Market by Route of Administration
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Peptide Hormone Market Overview
9.4.2 Middle East and Africa Peptide Hormone Market Forecasts and Analysis
9.4.3 Middle East and Africa Peptide Hormone Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Peptide Hormone Market Forecasts and Analysis - By Route of Administration
9.4.5 Middle East and Africa Peptide Hormone Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Peptide Hormone Market
9.4.5.1.1 South Africa Peptide Hormone Market by Type
9.4.5.1.2 South Africa Peptide Hormone Market by Route of Administration
9.4.5.2 Saudi Arabia Peptide Hormone Market
9.4.5.2.1 Saudi Arabia Peptide Hormone Market by Type
9.4.5.2.2 Saudi Arabia Peptide Hormone Market by Route of Administration
9.4.5.3 U.A.E Peptide Hormone Market
9.4.5.3.1 U.A.E Peptide Hormone Market by Type
9.4.5.3.2 U.A.E Peptide Hormone Market by Route of Administration
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Peptide Hormone Market Overview
9.5.2 South and Central America Peptide Hormone Market Forecasts and Analysis
9.5.3 South and Central America Peptide Hormone Market Forecasts and Analysis - By Type
9.5.4 South and Central America Peptide Hormone Market Forecasts and Analysis - By Route of Administration
9.5.5 South and Central America Peptide Hormone Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Peptide Hormone Market
9.5.5.1.1 Brazil Peptide Hormone Market by Type
9.5.5.1.2 Brazil Peptide Hormone Market by Route of Administration
9.5.5.2 Argentina Peptide Hormone Market
9.5.5.2.1 Argentina Peptide Hormone Market by Type
9.5.5.2.2 Argentina Peptide Hormone Market by Route of Administration
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PEPTIDE HORMONE MARKET, KEY COMPANY PROFILES
11.1. BIOPARTNERS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BOEHRINGER INGELHEIM GMBH
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ELI LILY AND COMPANY
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. INNOVATE BIOPHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MERCK KGAA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOVO NORDISK
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. F. HOFFMAN-LA-ROCHE LTD.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SANOFI
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TARIX PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. BioPartners
2. Boehringer Ingelheim GmbH
3. Eli Lily and Company
4. Innovate Biopharmaceuticals
5. Merck KGaA
6. Novo Nordisk
7. Pfizer, Inc.
8. F. Hoffman-La-Roche Ltd.
9. Sanofi
10. Tarix Pharmaceuticals
TIPRE00009669
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking